Boothbay Fund Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-27,511
| Closed | -$1.17M | – | 1322 |
|
|
2020
Q3 | $1.17M | Buy |
+27,511
| New | +$1.17M | 0.07% | 321 |
|
|
2016
Q4 | – | Sell |
-3,146
| Closed | -$220K | – | 897 |
|
|
2016
Q3 | $220K | Buy |
+3,146
| New | +$220K | 0.05% | 432 |
|
|
2015
Q3 | – | Sell |
-3,122
| Closed | -$252K | – | 559 |
|
|
2015
Q2 | $252K | Buy |
+3,122
| New | +$252K | 0.1% | 202 |
|